Study: J&J’s Zytiga Can Eliminate Some Prostate Tumors

A study looking at small group of men with prostate cancer showed the use of Johnson & Johnson’s Zytiga eliminated or greatly reduced the size of prostate tumors in one-third of patients treated for six months before surgery.
The Wall Street Journal